|
Name: 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine
Type: Psychoactive compound
AKA: TCPy
![1-[1-(2-Thienyl)cyclohexyl]pyrrolidine image](https://grammasearch.com/dev/v2/aiimages/1-%5B1-%282-thienyl%29cyclohexyl%5Dpyrrolidine.png)
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
![1-[1-(2-Thienyl)cyclohexyl]pyrrolidine image](/dev/v2/pages/pubchem_images/62764.png)
|
|
IV. History
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine (TCP) is a dissociative anesthetic and analog of phencyclidine (PCP). It was developed for its anesthetic properties but has primarily been used in research settings. TCP has hallucinogenic effects similar to PCP and is subject to regulation due to its potential for abuse and psychological effects.
|
|
V. Legal Information
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine, a synthetic dissociative, is often regulated under analog laws due to its psychoactive effects and potential for abuse. In the US, it might fall under the Federal Analog Act if similar to other controlled substances. Internationally, its legal status reflects efforts to control novel psychoactive substances and manage associated risks.
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine, a dissociative anesthetic, produces hallucinogenic effects. As an upper, it causes altered perception and euphoria. Short-term effects include dissociation and hallucinations, while long-term use may lead to psychological issues. Overdose risks involve severe agitation and psychosis. Safe use involves cautious dosing and supervision. Recent research emphasizes its hallucinogenic properties and the potential for misuse.  |
|
VII. Psychological Effects
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine, a dissociative anesthetic, affects glutamate receptors, leading to altered perception and euphoria. Immediate effects include dissociation and mood changes, while long-term use may cause cognitive impairments and psychological issues. Research focuses on its safety profile, therapeutic uses, and potential for abuse.
 |
|
VIII. Culture
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine is a dissociative anesthetic, classifying it as a downer. Short-term use induces dissociation and anesthesia, while long-term use can lead to dependence, cognitive impairment, and urinary issues. Overdose risks include severe dissociation, respiratory depression, and potential for psychosis. Safe dosages are typically controlled in medical settings. Recent research underscores its effectiveness in anesthesia but warns of potential cognitive and urinary side effects. Physical effects include dissociation, drowsiness, and potential for impaired motor functions.
 |